Nulibry Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

nulibry

tmc pharma (eu) limited - fosdenopterin hydrobromide dihydrate - metal metabolism, inborn errors - Önnur meltingarvegi og efnaskipti vörur, - nulibry is indicated for the treatment of patients with molybdenum cofactor deficiency (mocd) type a.

Tolvaptan Accord Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

tolvaptan accord

accord healthcare s.l.u. - tolvaptan - Óviðeigandi adh heilkenni - Þvagræsilyf, - tolvaptan is indicated in adults for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (siadh).

Sutent Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

sutent

pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - Æxlishemjandi lyf - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.

Incruse Ellipta (previously Incruse) Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

incruse ellipta (previously incruse)

glaxosmithkline (ireland) limited - skert umbrot brómíð - lungnasjúkdómur, langvarandi hindrandi - lyf til veikindi öndunarvegi sjúkdómum, - tilkynnt sem viðhaldsberkjuvíkkandi meðferð til að létta einkenni hjá fullorðnum sjúklingum með langvinna lungnateppu (copd).

Vyxeos liposomal (previously known as Vyxeos) Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

vyxeos liposomal (previously known as vyxeos)

jazz pharmaceuticals ireland limited - daunorubicin hydrochloride, cytarabine - kyrningahvítblæði, mergbólga, bráð - Æxlishemjandi lyf - vyxeos liposomal er ætlað fyrir meðferð fullorðnir með nýlega greind, meðferð-tengjast bráð merg hvítblæði (t-aml) eða aml með mergmisþroski-breytingar (aml-yngri og yngri).

Aspendos Tafla 100 mg Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

aspendos tafla 100 mg

medochemie limited - modafinilum inn - tafla - 100 mg

Clariscan Stungulyf, lausn 0,5 mmól/ml Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

clariscan stungulyf, lausn 0,5 mmól/ml

ge healthcare as - acidum gadotericum inn - stungulyf, lausn - 0,5 mmól/ml

Clariscan Stungulyf, lausn í áfylltri sprautu 0,5 mmól/ml Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

clariscan stungulyf, lausn í áfylltri sprautu 0,5 mmól/ml

ge healthcare as - acidum gadotericum inn - stungulyf, lausn í áfylltri sprautu - 0,5 mmól/ml

Pluvicto Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

pluvicto

novartis europharm limited  - lutetium (177lu) vipivotide tetraxetan - stækkun Æxli, gelding-Þola - heilsueyðandi lyf - pluvicto in combination with androgen deprivation therapy (adt) with or without androgen receptor (ar) pathway inhibition is indicated for the treatment of adult patients with progressive prostate-specific membrane antigen (psma)-positive metastatic castration-resistant prostate cancer (mcrpc) who have been treated with ar pathway inhibition and taxane based chemotherapy.

Abstral Tungurótartafla 800 míkróg Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

abstral tungurótartafla 800 míkróg

kyowa kirin holdings b.v. - fentanylum cítrat - tungurótartafla - 800 míkróg